logo-loader
RNS
Renold PLC

Renold PLC - Re: Directorate Change

RNS Number : 9241Z
Renold PLC
24 September 2020
 

Renold plc

("Renold", "the Company" or "the Group")

 

Directorate Change

 

24 September 2020

 

Renold, a leading international supplier of industrial chains and related power transmission products, announced on 12 May 2020 that Jim Haughey was to be appointed Group Finance Director. The Company is pleased to confirm that Jim will join the Board in this capacity with effect from 1 October 2020.

 

Jim has extensive experience of listed companies with multinational and manufacturing operations, at FKI plc, Bridon International Ltd, Cosalt plc, Bodycote plc and Mpac Group plc and joins Renold from his latest appointment at Drive Devilbliss Healthcare Ltd.

 

Mark Harper, Chairman of Renold plc commented:

 

"The Board is delighted to welcome Jim to Renold and looks forward to his contribution to the operational and strategic development of the Group."

 

 

ENQUIRIES:

 

Renold plc 

0161 498 4500

Robert Purcell, Chief Executive

 

 

 

 

 

Peel Hunt

0207 418 8831

Mike Bell

Ed Allsopp

 

 

 

 

Instinctif Partners

0207 457 2020

Mark Garraway

 

Rosie Driscoll

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKKNBQPBKDOCB
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read